Gary M. Levin, BA, CTR Florida Cancer Data System NAACCR 2008 Annual Conference 2007 Multiple Primary Rules: Impact on Tumor Counts.

Slides:



Advertisements
Similar presentations
1 TCR TUMOUR MATCHING ALGORITHM The structure of the algorithm- Heather Bourne Using the algorithm - Jason Hiscox.
Advertisements

Hematopoietic and Lymphoid Neoplasm Project. Acknowledgments American College of Surgeons (ACOS) Commission on Cancer (COC) Canadian Cancer Registries.
1 Renal Pelvis, Ureter, Bladder and Other Urinary.
Preventing Cancer with Healthy Life Styles Li-Fen L. Chang, M.D., Ph.D. Radiation Oncology SOMC Cancer Center.
National Institute of Oncology Rabat-Morocco. National Institute of Oncology I.N.O. Rabat, Morocco : New Cases.
Tumour Matching N.Ireland Experience Colin Fox (IT Manager) Richard Middleton (Data Manager)
Cancer Registry Coding Changes for 2014 Presented by the Kentucky Cancer Registry February, 2014.
Hematopoietic and Lymphoid Neoplasm Project. Primary Site and Histology Rules Peggy Adamo, RHIT, CTR NCI SEER October 2009.
TRAM Educational Conference September 19, 2014 Meritus Medical Center 1.
BMP receptor1a Amit Patel Estimated US Cancer Deaths* ONS=Other nervous system. Source: American Cancer Society, Men 295,280 Women 275,000.
Evaluation of Electronic Radiotherapy Data for Quality Checking Cancer Registry Data Colin Fox (NICR) Richard Middleton (NICR) Denise Lynd (BCH – COIS)
USPHS Scientific and Training Symposium University of Maryland School of Public Health College Park, Maryland Track 2 - Clinical and Community Preventive.
Cancer registries and rare cancers: quality of data, supplementary information RARECARE WP6 3rd meeting National Institute of Public Health Warsaw 25th.
Body Planes, Directions, & Cavities
1 LUNG. 2 Equivalent Terms, Def, Charts, Tables, Illustrations.
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Overview of All SEER-Medicare Publications Through 2012 Mark D. Danese, MHS, PhD July 24, 2012.
Cancer as a genetic chapter 23 select topics and lecture notes.
1 MP/H Coding Rules General Instructions MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Hematopoietic and Lymphoid Neoplasm Project. Acknowledgments American College of Surgeons (ACOS) Commission on Cancer (COC) Canadian Cancer Registries.
Human Biology Sylvia S. Mader Michael Windelspecht
Head and Neck MP/H Task Force Multiple Primary Rules
CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.
1 Cancer Etiology Dan Aderka MD Molecular mechanisms Environment Cancer cells.
Regulating the Cell Cycle Biology 392 Chapter 10-3.
Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.
BODY PLANES, DIRECTIONS, AND CAVITIES
1 Head and Neck. 2 Equivalent Terms, Definitions, Charts, Tables and Illustrations Primary site –Do not code biopsy site.
What’s the Diff? Sue C. Vest, CTR Missouri Cancer Registry This project was supported in part by a cooperative agreement between the Centers for Disease.
WE WILL ALL DIE OF CANCER If something else doesn’t kill us first HYPOTHESIS:
HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800.
Slides last updated: October Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Cancer.
1 Cutaneous Melanoma MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Regulating the Cell Cycle
Hematopoietic and Lymphoid Neoplasm Project. Acknowledgments American College of Surgeons (ACOS) Commission on Cancer (COC) Canadian Cancer Registries.
Cancer as a genetic chapter 21 pp & lecture notes.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
6 th Annual Focus Users’ Conference 6 th Annual Focus Users’ Conference Import Testing Data Presented by: Adrian Ruiz Presented by: Adrian Ruiz.
New Data Items MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Slides last updated: March Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN.
BY FRANCES ROSS, CTR PRESENTED AT THE NAACCR ANNUAL CONFERENCE JUNE, 2008 Record Consolidation Test with the 2007 Multiple Primary/Histology Rules.
Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.
1 Virginia Cancer Registrars Association and Virginia Cancer Registry Annual Meeting October 3, 2007.
Using NAPIIA to Improve the Accuracy of Asian Race Code in Registry Data Mei-Chin Hsieh, MSPH, CTR Lisa A. Pareti, BS, RHIT, CTR Vivien W. Chen, PhD NAACCR.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
1. Multiple Primary and Histology Rules 101 Format of MP/H Materials.
Is Your Data Management System Flexible for Quality Control Activities? Winny Roshala, CTR Data Standards and Quality Control Unit NAACCR: June 13-19,
Electronic CAP Cancer Checklists and Cancer Registries – A Pilot Project 2009 NAACCR Conference Ken Gerlach, MPH, CTR Castine Verrill, MS, CTR CDC-National.
Enhancing Incidence Data with Passive End-Results Jill MacKinnon, Sarah Manson, and Mayra Alvarez Florida Cancer Data System.
NPCR Data Completeness and Quality Audits Review of: Collaborative Stage and Surgery Data Mary Lewis, CTR NPCR Program Consultant.
Yueh-Han Hsu 1,2, MD, MPH, PhD; Wen-Chen Tsai 2, DrPH; Wei Chen 1, MD 1 Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi City, Taiwan 2.
2016 Edits.
Multiple Primary and Histology Coding Rules Colon Cancer
Cancer as a genetic chapter 21 pp & lecture notes.
Incidence and Treatment Patterns in Hospitalizations for Malignant Spinal Cord Compression in the United States, 1998–2006  Kimberley S. Mak, B.A., Leslie.
Quality Control Abstract Visual Review Process
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
CANCER Carbon Co. Luzerne Schuylkill Pennsylvania TABLE 1. Distribution of Cancers by Type for Tamaqua Study Counties and Pennsylvania Based on
RADIOLOGICAL ANATOMY OF THE LARGE BOWEL
Non-Communicable Diseases Lesson 7
SEER Case Consolidation Study: Design & Objective
Description of In Situ Tumors Reported to Cancer Registries,
Automated Consolidation of Collaborative Stage Data Items
What’s New for 8th Edition
Prepared by staff in Prevention and Cancer Control.
The Burden of Cancer in Nova Scotia an evaluation of loss in expectation of life Ron Dewar Registry and Analytics Presented to the joint NAACCR.
The Progress of npcr audits What have we done, what have we learned, and where are we going now Click to edit subtitle Click to enter your Division Name.
Text Mining for Data Quality Analysis of Melanoma Tumor Depth
Presentation transcript:

Gary M. Levin, BA, CTR Florida Cancer Data System NAACCR 2008 Annual Conference 2007 Multiple Primary Rules: Impact on Tumor Counts

Presentation Overview Florida Multiple Primary 2007 Automated Procedure Estimated Impact on Florida Tumor Counts Estimated Impact on Non-Florida Tumor Counts Conclusions Future 2

Special Thanks 3 To All Who Contributed To The MP2007 Algorithm Mayra Alvarez, RHIT, CTR Meg Herna, BA, CTR Jill MacKinnon, PhD, CTR Sarah Manson, BS, RHIT, CTR Mehrdad Nadji, MD Wendy Scharber, RHIT, CTR Brad Wohler, MS MP2007 Algorithm is CTR Driven

MP2007 Automated Procedures Design 4

5

MP2007 Automated Procedures Methodology Primary Site Pairs Histology Pairs Laterality Check Timing Rules Specialized Coded Rules for Deviation in Model 6

MP2007 Automated Procedures Methodology – Site Pairs 7 C160 1 C1611 C160 C1621 C160 C1631 C160 C1641 C160 C1651 C160 C1661 C160 C1681 C160 C1691 C160 C2682 C160 C2692 C161 C2682 C161 C2692 C162 C2682 C162 C2692 C163 C2682 C163 C2692 C164 C2682 Direct application of MP/H Rules Reasonable Extension of MP/H Rules (specific and general site) C030 C470S* C030 C490S* C031 C470S* C031 C490S* C039 C470S* C039 C490S* Correctly link Sarcoma cases C155 C1603 C159 C1603 Correctly link GE Junction cases C340 C3903 C341 C3903 C342 C3903 C343 C3903 C348 C3903 C349 C3903 Experience has shown are likely the same: - data sources - Level of automation - Review of results Slide Courtesy of Wendy Scharber

MP2007 Automated Procedures Methodology – Histology Pairs 8 First Version Needs further evaluation from: Registrars Pathologists Currently under review by Tumor Linkage Workgroup Slide Courtesy of Wendy Scharber

MP2007 Control Table 9 Primary SitesHistologyInvasive/ Insitu Timing Diagnosis TimingSchemaLaterality Check Schema IDClass Used in Timing C000-C148,C300-C , , Head and Neck Y10-2 C149-C179,C190-C299,C330- C339,C350-C439,C450- C499,C510-C609,C620- C648,C650-C658,C660- C668,C690-C699,C702- C709,C721-C724,C726- C727,C730-C750,C754-C , , , Other Sites Y20-2 C180-C , , Colon Y30-2 C340-C , , Lung Y40-2 C440-C Melanoma Y50-2 C440-C , , , Skin - Other Y60-2 C500-C BreastInflamatory N70-2 C500-C , , , Breast Y80-2 C Prostate-Epithelial N90-2 C , , Prostate - Other N100-2 C Prostate - General N110-2 C , , Kidney Y120-2 C Kidney - Wilms N130-2 C692,C Retinoblastoma N140-2 C700,C701,C710- C719,C720,C725,C728,C729, C751-C , , Brain N150-2 C000-C Kaposi Sarcoma N160-2 C659,C669-C , , Urinary System Y170-2 C000-C , Sarcoma Y180-2 Slide Courtesy of Wendy Scharber

MP2007 Automated Procedures Methodology – Specialized Code Urinary – M6 Rule Urinary – M8 Rule Other Sites – M5 Rule (Kaposi Sarcoma) Other Sites – M7 Rule (Ovary) 10

MP2007 Multiple Primaries Calculator 11

Data Background for Linkage Based on 3.2 Million Source Records from Florida Linked Diagnosis Year Present Includes Non-Analytic Cases – Primarily Class 3 Linkage done using Source Records Analysis Focuses on Diagnosis Year

Linkage Parameters Pre-MP2007 Rules Estimated Impact – Florida No Timing Rules Analytic/Non-Analytic Considered Equal Unknown Diagnosis Year use Date of First Contact 13

Linkage Parameters MP2007 Rules Estimated Impact – Florida MP2007 Rules Non-Analytic Cases - Skip Timing Rules Unknown Diagnosis Year - Skip Timing Rules 14

Timing Rule of > 5 years Minimal change in counts Removing Same Sites Table Examples: Upper/Lower Lip, Upper/Lower Gum Cannot Assess impact Original abstracting would have merged cases Estimated Impact – Florida Head and Neck 15 SitePre-2007MP2007DifferencePercent Gum, Other Mouth Floor of Mouth

Estimated Impact – Florida Colon 16 Sub-sitePre-2007MP2007DifferencePercent Cecum Appendix Ascending Colon Hepatic Flexure Transverse Colon Splenic Flexure Descending Colon Sigmoid Colon Large Intestine, NOS Rectosigmoid Junction Rectum Timing Rule > 1 year – Small change in counts – Timing Rule – Extension of Florida Site Pairs for 2007 Did not assess Familial Polyposis

Timing Rule of > 3 years Small change in counts Timing Rules Extensions of Florida Site Pairs for 2007 Non-Small Cell Adenocarcinoma with Small Cell Carcinoma Cannot Assess Original abstracting would have merged cases Estimated Impact – Florida Lung 17 SitePre-2007MP2007DifferencePercent Lung and Bronchus

No Changes in Timing Rule > 60 Days Small change in counts Extensions of Florida Site Pairs for 2007 Estimated Impact – Florida Melanoma 18 SitePre-2007MP2007DifferencePercent Melanoma of the Skin Melanoma Issue Midline Laterality is considered a separate primary. The MP2007 Procedure does NOT handle this. To properly identify Midline, would require additional resources which are NOT available. To be able to properly count Midline Melanoma would require NAACCR to consider adding a separate laterality code dedicated to Midline.

Timing Rule of > 5 years Small change in counts Timing Rules Inflammatory carcinoma is one primary Did Not Assess Estimated Impact – Florida Breast 19 SitePre-2007MP2007DifferencePercent Breast

Timing Rule of > 3 years Minimal change in counts Timing Rules MP2007 Rules split Kidney and Renal Pelvis Incidence Site Group includes both Kidney and Renal Pelvis Difficult to assess impact Estimated Impact – Florida Kidney 20 SitePre-2007MP2007DifferencePercent Kidney and Renal Pelvis

Timing Rule of > 3 years Changes in counts Rule M6 and M8 Removing Same Sites Table Multiple tumors on same side (M3, M4) MP 2007 Module does not include these rules at this time Estimated Impact – Florida Renal Pelvis, Ureter, Bladder etc. 21 SitePre-2007MP2007DifferencePercent Urinary Bladder Ureter Other Urinary Organs

Timing Rule of > 1 year Small change in counts Timing Rules Removing Same Sites Table Cannot Assess impact Original abstracting would have merged cases Estimated Impact – Florida Other Sites 22 SitePre-2007MP2007DifferencePercent Intrahepatic Bile Duct Liver Nose, Nasal Cavity and Middle Ear Cervix Uteri Larynx Other Endocrine including Thymus

Estimated Impact – Florida Totals 23 SitePre-2007MP2007DifferencePercent Present – No Change in Counts

Linkage Parameters Pre-MP2007 Rules Estimated Impact – Non-Florida Used Florida’s Data Used Florida MP2007 Procedure for Estimate Changed Timing Rules to 60 Days where applicable Reinstated Pre-MP2007 Site Pairs Non-Analytic - Skip Timing Rules Unknown Diagnosis Year - Skip Timing Rules 24

Linkage Parameters MP2007 Rules Estimated Impact – Non-Florida MP2007 Rules Non-Analytic - Skip Timing Rules Unknown Diagnosis Year - Skip Timing Rules 25

Timing Rule of > 5 years – Small Change Estimated Impact – Non-Florida Head and Neck 26 SitePre-2007MP2007DifferencePercent Gum, Other Mouth Floor of Mouth Breast SitePre-2007MP2007DifferencePercent Breast

Estimated Impact – Non-Florida Colon 27 Sub-sitePre-2007MP2007DifferencePercent Cecum Appendix Ascending Colon Hepatic Flexure Transverse Colon Splenic Flexure Descending Colon Sigmoid Colon Large Intestine, NOS Rectosigmoid Junction Rectum Timing Rule > 1 year – Small Change

Timing Rule of > 3 years – Small Change Estimated Impact – Non-Florida Lung 28 SitePre-2007MP2007DifferencePercent Lung and Bronchus Kidney SitePre-2007MP2007DifferencePercent Kidney and Renal Pelvis

Timing Rule of > 3 years - Change Estimated Impact – Non-Florida Renal Pelvis, Ureter, Bladder etc. 29 SitePre-2007MP2007DifferencePercent Urinary Bladder Ureter Other Urinary Organs Timing Rule > 60 Days – No Change SitePre-2007MP2007DifferencePercent Melanoma of the Skin Melanoma

Timing Rule of > 1 year - Change Estimated Impact – Non-Florida Other Sites 30 SitePre-2007MP2007DifferencePercent Intrahepatic Bile Duct Liver Nose, Nasal Cavity and Middle Ear Cervix Uteri Larynx Other Endocrine including Thymus

Estimated Impact – Non-Florida Totals 31 SitePre-2007MP2007DifferencePercent Present – Change in Counts

Conclusions 32 Small Percentage Change Due to New MP2007 Rules Need Further Analysis Need Detail Review of Unexpected Counts Need to Compare Incidence Rates WARNING “ Staring at Numerical Results Can be Dangerous to Your Health ”

Future NAACCR Tumor Linkage Workgroup Review Validation of Site Pairs Validation of Histology Pairs Evaluation of Florida MP2007 Algorithm NPCR Development of Generalized Algorithm for Use by All Registries. Plan to function similar to CS Add Scoring mechanism to weight the reliability of each linkage Continue to Analyze and Refine Algorithm/Procedure 33

Thank You 34 Questions